Suggestions
Anurag Dhingra
Co-founder - MediSage - - Former Healthcare Private Equity - - Redefining Healthcare marketing
Anurag Dhingra is a seasoned professional in the healthcare industry, currently serving as the Co-Founder of MediSage, a health tech platform designed to connect physicians, biopharma companies, hospitals, and device and diagnostic companies. This platform aims to facilitate digital engagement, market research, and new product development within the healthcare ecosystem.
Background and Education
- Education: Anurag holds a Post Graduate Diploma in Management (PGDM) from IIM Lucknow, specializing in Finance and Marketing, where he ranked in the top 10% in Term III. He also has a Bachelor of Technology (B.Tech.) in Electrical, Electronics, and Communications Engineering from the National Institute of Technology Kurukshetra.1
Professional Experience
- MediSage: Co-Founder since April 2021, focusing on building a digital ecosystem for healthcare stakeholders.1
- InvAscent: Served as Vice President of Investments from December 2018 to October 2021, responsible for sourcing and evaluating life sciences companies.1
- Board Observer Roles: Held observer positions at companies like MediBuddy, Strides Consumer Private Limited, Alniche Life Sciences Pvt. Ltd., and Comprehensive Prosthetics & Orthotics (CPO).1
- Early Career: Worked as a Senior Analyst and Business Analyst at Inductis (An EXL Company), focusing on credit risk modeling and workforce planning.1
Industry Insights
Anurag has developed strong capabilities in evaluating pharmaceutical and medical device businesses, having interacted with over 1000 entrepreneurs across various healthcare sectors. He is bullish on HealthTech, distribution, nutraceuticals, medical devices, and branded consumer healthcare.1
MediSage Overview
MediSage, founded in 2019, is a global knowledge platform for doctors that facilitates medical collaboration and knowledge sharing. It has raised $7 million in funding from investors like Bessemer Venture Partners and aims to expand its reach and product offerings.234